UROLOGY CANCERS
Urinary Bladder Cancer
Urinary bladder cancer, often simply referred to as bladder cancer, is a type of cancer that begins in the lining of the urinary bladder. Here is some essential information about bladder cancer:
More Information
Urinary Bladder Cancer
TYPES OF BLADDER CANCER:
The most common type of bladder cancer is transitional cell carcinoma (urothelial carcinoma), which originates in the cells lining the bladder. Other less common types include squamous cell carcinoma and adenocarcinoma.
​
RISK FACTORS:
Several factors may increase the risk of developing bladder cancer, including smoking, exposure to certain chemicals (e.g., from industrial work), chronic bladder infections, family history of the disease, and certain medications, like cyclophosphamide.
​
SYMPTOMS:
Common symptoms of bladder cancer may include blood in the urine (hematuria), frequent urination, painful urination, lower back pain, and abdominal pain. These symptoms can also be caused by other conditions, so it's essential to seek medical evaluation for a proper diagnosis.
​
DIAGNOSIS:
Bladder cancer is typically diagnosed through various tests, including urine analysis, cystoscopy (inserting a thin tube with a camera into the bladder), imaging scans (CT or MRI), and biopsy (removing a tissue sample for examination).
​
STAGING:
Staging determines the extent and severity of the cancer. Bladder cancer is often staged as non-invasive (confined to the inner layer of the bladder), invasive (penetrating deeper layers), or metastatic (spread to other organs or lymph nodes).
​
TREATMENT OPTIONS:
The choice of treatment for bladder cancer depends on the stage and type of cancer, as well as the patient's overall health. Common treatment options include:
-
Transurethral Resection of Bladder Tumor (TURBT): Removal of small, non-invasive tumors through a cystoscope.
-
Surgery: Partial or radical cystectomy (removal of part or all of the bladder) may be necessary for more advanced cases.
-
Chemotherapy: Medications to kill cancer cells, either intravesical (directly into the bladder) or systemic (throughout the body).
-
Immunotherapy: Drugs that stimulate the immune system to attack cancer cells..
-
Radiation Therapy: High-energy rays to target cancer cells.
​
SURVIVAL RATES:
The prognosis for bladder cancer varies based on the stage at diagnosis and other factors. Early-stage bladder cancer often has a more favorable prognosis. Survival rates improve with early detection and appropriate treatment.
​
FOLLOW-UP CARE:
After treatment, regular follow-up visits are essential to monitor for cancer recurrence and manage potential side effects of treatment.
Bladder cancer is a treatable disease, and outcomes can be favorable, especially when detected early. Individuals with symptoms or risk factors for bladder cancer should seek medical attention for prompt evaluation and appropriate care.